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Introduction
The assembly of glycosaminoglycan chains on core proteins is a multistep process that begins most often with the formation of a specific carbohydrate-protein linkage region and continues with the alternating addition of D-GlcUA 1 and either D-GlcNAc or D-GalNAc followed by sulfation and additional polymer modifications (see 1,2 for reviews). The two types of galactosaminoglycans, chondroitin sulfate and dermatan sulfate, are primarily distinguished by the absence or presence of L-IdoUA residues, respectively. The C-5 inversion of D-GlcUA to L-IdoUA occurs on the polymer level (3) and involves an abstraction of the C-5 hydrogen of the uronosyl residues (4) . Sulfation at carbon atom 4 of adjacent galactosamine residues prevents back-epimerization to D-GlcUA (3, 5) . The responsible enzyme, chondroitin-glucuronate 5-epimerase (EC 5.3.1.19), has not yet been characterized at the molecular level. However, a two-base reaction mechanism was postulated, involving a monoprotic L-ido-specific base and a polyprotic D-gluco-specific base, during the action of the enzyme on an E. coli-derived capsular polysaccharide (6) . The C-5 epimerization of the 1-4 linked GlcUA residues in heparan sulfate is accomplished by the action of a different enzyme (7) , named heparosan N-sulfate-glucuronate 5-epimerase (EC 5.3.1.17), which has been characterized by cDNA cloning (8) and kinetic studies (9) .
Iduronic acid-containing glycosaminoglycans have a greater conformational flexibility than glycosaminoglycans composed only of GlcUA as the hexuronic acid moiety (10) (11) (12) (13) (14) .
Additionally, L-IdoUA residues are more frequently 2-O-sulfated than D-GlcUA residues, allowing the appearance of clustered, highly charged domains along the glycosaminoglycan chain. Hence, the degree of epimerization is of functional relevance. For example, only dermatan sulfate and not chondroitin sulfate can stimulate thrombin inhibition by heparin cofactor II (15) (16) (17) , and an altered dermatan sulfate structure may be of pathophysiological importance during the development of arteriosclerosis (18) .
Various cell types synthesize simultaneously proteoglycans of the lectican family (reviewed in 19) , which carry multiple chondroitin sulfate chains, and proteoglycans of the small leucine-rich protein family (reviewed in 20) . DCN and biglycan are the most intensely studied members of the latter family. They carry either only one or two galactosaminoglycan chains, which, with some exceptions, are rich in L-IdoUA residues (21, 22) . Whereas the variability of epimerization within the family of small leucine-rich proteoglycans may be explained by differences in the activity of chondroitin-glucuronate 5-epimerase, the reasons for the different extent of epimerization of proteoglycans being synthesized by the very same cell are not yet understood. Several not mutually exclusive hypotheses may explain the experimental findings. The respective core proteins may influence epimerase activity, or may alter the degree of modification of the linkage region components GlcUA-Gal-Gal-Xyl by phosphorylation and/or sulfation, which may be important for subsequent biosynthetic events (23) . Alternatively, different proteoglycans may encounter different multi-component complexes of synthesizing enzymes with different epimerase activities along their transport from the endoplasmic reticulum to the trans-Golgi network. To address these possibilities, we generated chimeric core proteins composed of truncated forms of two proteoglycans, each characterized by the presence of a single glycosaminoglycan chain. The N-terminal part of DCN, a small leucine-rich proteoglycan carrying a dermatan sulfate chain, was linked with the central portion of the proteoglycan form of CSF-1 (M-CSF), which is characterized by the presence of a single chondroitin sulfate chain (24) (25) (26) (27) . Additional mutants, truncated in the CSF-1 moiety were also generated. It was shown previously that individual MG-63 osteosarcoma cells can express simultaneously DCN and the proteoglycan form of CSF-1, which differ greatly in their D-GlcUA/ L-IdoUA ratios (21) .
EXPERIMENTAL PROCEDURES
Construction of chimeric cDNA -First, the cDNA for DCN M1-Q153 including 120 bp of the 5'-untranslated sequence and a stop codon was amplified by PCR from full-length human cDNA (28) in pGem3Z, by using the primer pair 5'-TAATACGACTCACTATAG-3' (T7-forward primer) and 5'-CTGAAGAGTTTTGGGCATTTTTTC-3' (reverse and complement primer). Similarly, the cDNA for L241-V554 of CSF-1 in pGem-T (27) including a downstream located part of the vector sequence was amplified by using the T7-forward , truncated and mutant chimeras were generated by using the Trisacryl M (Serva) to recover the proteoglycans as described (30) .
Isolation of DCN-and CSF-1-Attached Glycosaminoglycan Chains -The principle for
the separation of DCN-and CSF-1-attached glycosaminoglycan chains was to block all free amino groups, then to digest the proteoglycan proteolytically and to biotinylate the newly formed amino groups. A protease was chosen that could not act N-terminally to the DCNspecific attachment site. After protease cleavage, therefore, only chains on the CSF-1 site will have newly exposed N-termini available for biotinylation. After biotinylation the two glycosaminoglycan chains were separated by affinity chromatography on avidin-Sepaphose.
In detail, the extracted proteoglycan was made 0.1 % with SDS, dialyzed against water and concentrated 10 fold under reduced pressure. A 100 µl sample of each was mixed with 100 µl N-ethylmorpholine and 150 µl freshly prepared dansyl chloride (25 mg/ml N,Ndimethylformamide). The sample was mixed end over end for 3 h at room temperature before the proteoglycan was precipitated with 1 ml of acetone. Upon centrifugation, the pellet was washed with 80 % acetone and dried in air. Subsequently, the sample was redissolved in SDS sample buffer and subjected to gel electrophoresis, gel extraction and DEAE-chromatography as described above. Appropriate aliquots were exhaustively digested with 1000 units of trypsin, and the radioactive degradation products were rechromatographed on DEAE- conditions were employed or where the degrading enzyme was added a second time after the first incubation step and incubation continued for an additional 2 h period. At the end of the incubation, heparin was added as carrier (50 µg per assay), and the samples were subjected either to size fractionation or to ethanol precipitation as described below.
Size fractionation of oligosaccharides was done on a Superdex Peptide HR 10/30 column (Pharmacia Biotech) equilibrated and eluted with 0.5 M NH 4 HCO 3 at a flow rate of 0.5 ml/min. Fractions of 150 µl were collected, and small aliquots were taken for liquidscintillation counting or hexuronic acid determination. The column was calibrated with a chondroitin sulfate disaccharide, a trisulfated heparan sulfate trisaccharide and a heparan sulfate dodecasaccharide fraction as described (35) . The total amount of disaccharides released by chondroitin ABC lyase was taken as 100 % of chondroitin sulfate and dermatan sulfate disaccharide units. In chondroitin AC lyase digests, the percentage of chondroitin sulfate disaccharide units was obtained by adding all radioactivity in disaccharides, 50 % of the radioactivity in tetra-, and 33 % of that in hexasaccharides, and comparing this quantity with the amount of chondroitin ABC lyase-generated disaccharides. Analogous calculations were made for the dermatan sulfate disaccharide units in the products of chondroitin B lyase digestions.
During the course of the study it became apparent that a much simpler method yielded the same results with a variation of less than ±5 %. The lyase-digested proteoglycan solution was mixed with 4 volumes of ethanol and stored over night at -20°C. After thawing and centrifugation for 10 min at 10,000 x g, an aliquot of the supernatant was carefully removed and subjected to liquid scintillation counting. After 2 washing steps with ethanol, the pellet was solubilized in 1 M NaOH, and its radioactivity was also determined. When the two fractions were separately subjected to high performance gel filtration as described above, the ethanol-soluble fraction contained to at least 95 % di-and tetrasaccharides, while the ethanolinsoluble material was composed of hexa-and higher saccharides. The radioactivities of the ethanol supernate and of the pellet were related to each other without using corrective factors.
Fluorophore-assisted carbohydrate electrophoresis (36) after chondroitin ABC, ACII, and B lyase digestion, respectively, was used to determine the ratio of 4-and 6-sulfated Nacetylgalactosamine-containing disaccharides in the chondroitin sulfate-and dermatan sulfate-containing domains of the glycosaminoglycan chains of the various chimeric proteins. from Streptomyces hyalurolyticus (Sigma) for 2 h at 37°C and subjected to ammonium sulfate precipitation and chromatography on 0.5 ml of DEAE-Trisacryl M (SERVA) column as described except that the starting buffer contained only 50 mM NaCl. The column was washed with buffer containing 100 mM NaCl, and proteoglycans were desorbed from the resin with 1.0 ml of 300 mM NaCl in 20 mM Tris/HCl, pH 7.2.
In-vitro-Assay of 5-Glucuronate Epimerase Activity
The source of 5-glucuronate epimerase was a freshly prepared suspension in 50 mM HEPES, pH 6.5, of the 10,000 g pellet obtained from the post-nuclear supernatant of 293 cells as described (7) . The crude enzyme preparation (3. Other Methods -Polyacrylamide gel electrophoresis in the presence of SDS followed by fluorography was done as previously described (30) . The two core protein fragments used to obtain the chimera were also expressed individually whereby the CSF-moiety was combined with the DCN prepro sequence to allow secretion into the culture medium. For better yields, DCN Q153 and the chimeras shown in Fig.   3C were purified by anion exchange chromatography on DEAE Trisacryl. This resin exhibits some molecular sieve properties; e.g. it does not retain the large proteoglycan aggrecan (unpublished observation). Therefore, the chimera could be separated from other high (Fig. 3B) . This observation is a strong argument for inappropriate folding of the CSF-1 moiety when expressed without the DCN fragment M1-Q153. However, as indicated above, the full-length chimera showed neither inappropriate secretion nor abnormal electrophoretic mobility. Furthermore, pulse-chase experiments of 293 cells transfected either with the chimera or with full-length DCN using [ 35 S]methionine as a radioactive precursor did not reveal significant differences in the secretion kinetics (data not shown). Other chimeric proteins behaved as expected during SDS-PAGE (Fig. 3C) .
The Glycosaminoglycan Chains of the Chimera Contain Minute Amounts of L-IdoUA
Residues -The [ 35 S]sulfate-labelled biglycanated form of the chimera was isolated from conditioned medium by ion exchange chromatography and SDS-PAGE. The proteoglycan extracted from the gel was subsequently subjected to parallel treatments with chondroitin lyases ABC, ACI, and B, respectively. Each digest was then subjected to chromatography on a Superdex Peptide HR 10/30 column. It is evident from Fig. 4 and Table II that (Table II) . This result corroborates the finding of the extremely low epimerization degree in both glycosaminoglycan chains of the chimeric proteoglycan. Mutating either one of the serine residues, which serve as attachment sites for glycosaminoglycan chains, into alanine residues also does not change the epimerization pattern of the monoglycanated proteoglycan (Table II) .
The Core Protein of the Chimera is Not Responsible for the Low Degree of Epimerization -
To investigate the possibility that the chondroitin-glucuronate 5-epimerase may require distinct structural features on the core protein that are absent in the chimera, undersulfated An unexpected finding was our observation that the removal of only 28 amino acids of a truncated DCN/CSF-1 chimera (converting chimera P231 into chimera G203, see Fig. 1) enabled the cells to epimerize the chimera´s glycosaminoglycan to an extent resembling that of wild-type DCN. It appears, therefore, that there is a signal within the sequence of these 28 amino acids which is responsible for the avoidance of epimerization. This signal is needed for maintaining the initially synthesized chondroitin sulfate structure, while the formation of dermatan sulfate follows a default pathway. An alternative explanation could be the formation within the transfected cells of non-physiological complexes between the C-terminal part of the CSF-1 moiety and the glycosaminoglycan chains with a subsequent inability of the complex to become modified by the epimerase. We consider this as an unlikely event since it is hard to imagine how a peptide of 28 amino acids masks simultaneously the two high molecular weight chondroitin sulfate chains of the intact chimera.
Considering the core protein as a major determinant for glucuronide C5-epimerization, In summary, our data provide evidence that dermatan sulfate is synthesized by a default pathway. A putative signal sequence preventing epimerization by the chondroitinglucuronate 5-epimerase has been identified. Further studies, however, are required, e.g. by deleting the putative signal sequence in chondroitin sulfate proteoglycans, before the function of this sequence for glycosaminoglycan modification can be unambiguously defined.
TABLE I

Overview of recombinant proteins
In all chimeric proteins the numbering of amino acids is based on the sequence of the construct and not on the sequence of the natural precursor proteins. and chondroitin B lyase (B), respectively. The digestion products were subjected to the ethanol precipitation procedure. The recovery of total radioactivity in ethanol pellet and supernatant was 100 ± 5 %. The range of data from four independent experiments, each one done in duplicate, is given. 3 H-labelled proteoglycans were digested in parallel with chondroitin ABC lyase, chondroitin ACI lyase (ACI) and chondroitin B lyase (B), respectively, and subjected to ethanol precipitation. The radioactivity in the supernatant was expressed as percent of ABCreleasable radioactivity after correction by the buffer control values (~ 1 % of total radioactivity). The table shows the data from one of two experiments. The second experiment yielded almost identical results. 
Construct
TABLE V
Epimerization degree of truncated, monoglycanated proteoglycans
The experimental details are as described in the legend of Table II . The range of data of three independent experiments is given. , is abbreviated by Q153. ABC + denotes digestion with chondroitin ABC lyase prior to SDS-PAGE. In B the recombinant fragment (frag) of CSF-1 was isolated from the culture medium by immunoprecipitation with a polyclonal antibody against the growth factor. Other proteoglycans were obtained after chromatography on DEAE-Trisacryl. In C all samples had been treated with chondroitin ABC lyase after immune precipitation. by guest on November 6, 2017
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